Barclays lifts Labcorp target to $380, keeps Equal-Weight
Alpha Vantage · TradingView · · AI-summarised by FinFlash
Barclays maintained an Equal-Weight rating on Labcorp Holdings while raising its price target to $380 from $330, a 15.2% increase. The new target implies 5.5% upside from the stock's October 28 close of $360.25. Analyst ratings on Labcorp stand at 13 Buy, 4 Hold and 1 Sell.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.